Two GDP Non-Compliance Reports published in March
Recommendation
9 September 2025
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
Register now for ECA's GMP Newsletter
Two new GDP Non-Compliance Reports have recently been published in the EudraGMDP database, both following the identification of serious violations of Good Distribution Practice (GDP) requirements.
The first report, dated 20 March 2025 (report number: NCCENTROM/2025/001, inspection date: 11 December 2024), was issued by the Competent Authority of Cyprus (Pharmaceutical Services, Ministry of Health). It states that the wholesale distributor had supplied medicinal products to unauthorized entities, which is a clear violation of GDP standards.
The second report, dated 26 March 2025 (report number: 482076-103624037, inspection date: 04 December 2024), was published by the Austrian Federal Office for Safety in Health Care. Here, the authority notes in general terms that the distributor does not comply with the EU GDP Guideline, without specifying further details.
In both cases, the respective Wholesale Distribution Authorisation (WDA) was withdrawn.
Source: EudraGMDP Database *
* To find the respective report, please click on "Non-Compliance Reports" in the menu on the left-hand side and select in "From Date / To Date" the month the inspection took place. After clicking on "Search" the results list will be displayed, from which you can choose the report with the number mentioned above.
Related GMP News
10.06.2025Stimuli Article Proposes Revision of USP Definition of Controlled Room Temperature (CRT)
10.06.2025New MHRA Blog Post: Supplying Medicines to Ships, Aircraft and Oil Platforms
10.06.2025Questions and Answers from the ECA Webinar "GDP Update 2025" - Part 3
10.06.2025Meet the GDPA Board Members at the GDP Forum in Barcelona
10.06.2025Swissmedic Technical Interpretation: What Counts as a Major Change in GDP?
10.06.2025MHRA informes about Validity Date of UK issued GDP Certificates